-
Thematic Analysis
Social Responsibility Trends in Healthcare – Thematic Intelligence
This report analyzes the impact of social responsibility pressures on the Healthcare sector. Who Should Buy Senior executives and ESG executives in Healthcare industry.
-
Thematic Analysis
Social Responsibility Trends by Sector – Thematic Intelligence
Social Responsibility Trends Thematic Report Overview The world demographics is likely to be influenced by several factors, for instance, Africa’s bulging youth population, continued global economic inequality, and aging populations will shape world demographics in 2030. This could be attributed to the high fertility rates and decreasing infant mortality rates in the country. There were many social issues coming under the spotlight in 2022 creating pressure on companies to act on social responsibility, which looks at a company’s engagement with...
-
Thematic Analysis
Digital Marketing Trends in Psoriasis
Digital Marketing Trends in Psoriasis Report Overview AbbVie's Skyrizi.com achieved the highest total traffic across branded PsO patient sites in the US with almost 7.2 million visitors between January 2022-December 2022. This was followed by Novartis's Cosentyx.com (3.3 million visits) and AbbVie's Humira.com (2.3 million visits). Amgen spent the most on digital display advertising (DDA) for Otezla.com, followed by Enbrel.com. Cosentyx.com was supported by the most paid search engine optimization, followed by Otezla.com and Stelarainfo.com. The digital marketing trends in...
-
Thematic Analysis
Impact of Brazil on the Pharmaceutical Industry – Thematic Intelligence
Brazil Pharmaceutical Market Report Overview Brazil is the largest pharmaceutical market in Central/Southern America and is the 12th largest in the world. Brazil is an untapped market for big pharma manufacturing, with domestic companies dominating the marketed products landscape. The domestic pharmaceutical companies will continue to grow due to favorable policies provided by the Brazilian government to promote domestic production of medicines. Furthermore, over the years, Brazil has elevated its infrastructure, scientific, and technological facilities and has created a sustainable...
-
Thematic Analysis
Drug Manufacturing Sector Scorecard – Thematic Intelligence
Pharma supply chains are complex processes through which drugs are developed, manufactured, and delivered to patients. Additionally, outsourced manufacturing is a key supply chain component which is primarily driven by increased drug consumption and the development of more advanced treatments. Therefore, pharma companies are under increasing pressure to ensure supply chain sustainability and resilience. Environmentally sustainable supply chains and manufacturing involve reducing greenhouse gases, improving air quality and water management, and more renewable energy usage. Social sustainability ensures that patients...
-
Report Bundle
47% offESG in Sectors – Report Bundle (8 Reports)
Companies with good ESG practices reflect on their commitment to adopt environmentally conscious business decisions combined with strong social responsibility and corporate governance. ‘ESG in Sectors’ acts as a catalyst for creating business opportunities, attracting investors, increasing employee productivity, and reducing regulatory interventions. As a part of this bundle, you will gain access to in-depth insights available in the following reports: Thematic Research: ESG in Retail & Apparel Thematic Research: ESG in Financial Services Thematic Research: ESG in Construction Thematic...
-
Report Bundle
26% offTrends in Pharma – Report Bundle (4 Reports)
‘The pharmaceutical sector is witnessing a massive revamp. It has been conventionally slow in the adoption of technology and is now undergoing rapid changes due to the development of several technologies as well as innovations. From modern cancer research facilities to gene treatment centers, the novel association between the human mind and technology has become a self-evolving matter. Post-COVID, equipped with cutting-edge technology, the prominent pharma industry tends to invest increasingly in inter-organizational collaborations to boost a favorable environment for...
-
Report Bundle
58% offTech in Pharma – Report Bundle (7 Reports)
Tech in Pharma Bundle Report Overview Although the pharmaceutical industry had been slow to adopt technological innovations, the onset of COVID-19 has dramatically altered the situation. The latest technologies, Augmented Reality (AR), Big Data, and Artificial Intelligence (AI), among others, will assist pharmaceutical companies in speeding up the research and development process, creating personalized products, and conducting testing in novel ways. Finally, these technologies will improve healthcare effectiveness and efficiency thereby transforming the patient and provider experience. Explore actionable market...
-
Report Bundle
20% offTrends in Healthcare – Report Bundle (4 Reports)
Trends in Healthcare Industry Bundle Report Overview The healthcare sector is one of the largest industries which is developing with the evolution of technology. Provisions such as telemedicine and the digitalization of personal data have made life easier for both patients and healthcare providers. The maintenance of patient information via electronic health records (EHRs) results in easy access for patients and doctors as well as improved medical care. Accessing the in-depth insight from the Trends in Healthcare bundle can help you:...
-
Report Bundle
37% offDigital Health – Report Bundle (5 Reports)
Digital Health Bundle Report Overview The significance of digital health cannot be overstated. While assisting people in monitoring and managing chronic illnesses, digital health has the potential to prevent disease and save healthcare expenditures. Automation, digitalization, and big data analysis could propel the emergence of digital health. “Digital Health” helps in exploring the various applications that will shape the global healthcare industry. Accessing the in-depth insight from the Digital Health bundle can help you: Make informed decisions about investments, partnerships, and...